Air France KLM Martinair Cargo says that they are ready and able to transport vaccines if and when they become available for COVID-19.
Since the start of the COVID-19 crisis, the air carrier says they have gradually rebuilt their network mainly for relief-related shipments. In recent months, they have mainly been operating on a cargo-only basis. They have been using their passenger aircraft for cargo charter purposes and have fully utilized their full-freighter fleet. Since the start of the pandemic, the carrier has operated more than 5500 cargo-only flights. AFKLMP Cargo currently offers a network spanning more than 95 long-haul destinations.
Shipping pharma and healthcare products is a core activity for AFKLMP Cargo. In recent years, the carrier has invested in infrastructure at both of their hubs, Paris Charles de Gaulle (CDG) and Amsterdam Schiphol (AMS), and have fully merged thier booking and service options via their digital portal myCargo.
GertJan Roelands, SVP of Sales & Distribution at AFKLMP Cargo: “Shipping pharma and other medical-related goods is one of our core activities and a strategic priority. From the start, we prioritized pharma commercially and operationally. At AFKLMP Cargo, we have a department that is fully dedicated to pharma and healthcare solutions. With this in mind, Air France and KLM were among the first airlines to obtain IATA CEIV certification.”
Enrica Calonghi, Global Head of Pharmaceutical Logistics at AFKLMP Cargo: “AFKLMP Cargo is ready to play a key role in the distribution of Covid-19 vaccines, thereby helping to ensure that as many people as possible around the globe will have access to vaccines in these challenging times.”